Clinical Studies On Treating Chronic Pelvic Inflammatory Disease (Syndrome Of Splenic Asthenia And Wet Accumulation And Blood Stasis) With Zhidai Tablets

Background: In recent years, accompany with the change of people's thought, the buildup of external communication, the increase of personal movement, the rising of sex intercourse and the increasing of uterine operate, the morbidity of chronic pelvic inflammatory disease (CPID) rise up obviously. There' s no specific therapeutic methods have noticeable effect in CPID. Western medicine major in applying antibiotic to cure CPID, however traditional medicine uphold to diagnose it from integer and to determinate treatment based in pathogenesis obtained through differentiation of symptoms and signs. As we known, CPID is a long-term, easily recurring disease. Traditional medicine thought that invalidism result in congestion and then damage healthy energy, so the type of splenic asthenia and wet accumulation and blood stasis is predominant in CPID.Objective: This investigation would to evaluate the clinical availability and clinic safety of ZhiDai Tablet to treat CPID (the type of splenic asthenia and wet accumulation and blood stasis), contrast with TaiNuoQing FuKe BaiDai Tablet.Method: We randomly elect 70 cases CPID patients whose age from 20 to 45 year in Guangdong Province Traditional Hospital hospital-based outpatient gynecological clinic, according to the diagnostic standard of western medicine about CPID and traditional medicine about CPID (the type of splenic asthenia and wet accumulation and blood stasis), adopt traditional medicine syndrome scoring table and physical sign scoring table to appraise the condition, and make a clinical observation of two medicines refer to the result of laboratory examination.Result: The investigation manifest that there isn' t statistic significance in total effective rate between two medicine to improve the integrated syndrome and region physical sign of CPID patient (the type of splenic asthenia and wet accumulation and blood stasis). The total effective rate of treating CPID in ZhiDai Tablet and TaiNuoQing FuKe BaiDai Tablet is 84. 37% and 69. 70% respectively, the total effective rate of improving integrated syndrome and region sign is 81. 25% and 72. 73%. ZhiDai Tablet is better than TaiNuoQing Fuke BaiDai Tablet in ameliorating the efficacy of abdominal pain. The therapeutic effect of this investigation isn' t correlation with patient' s general condition.Conclusion: ZhiDai Tablet could invigorate spleen to eliminate dampness and promote blood circulation and remove blood stasisi. There is better therapeutic effect to apply it to treat CPID (the type of splenic asthenia and wet accumulation and blood stasis).